Minimal Residual Disease in Hematological Malignancies

Publisher： Karger

E-ISSN： 1421-9662|112|1-2|5-7

ISSN： 0001-5792

Source： Acta Haematologica, Vol.112, Iss.1-2, 2004-06, pp. : 5-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Multiparametric Scanning System for Evaluation of Minimal Residual Disease in Hematological Malignancies

By  

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 24-29

Karger

Access to resources Recommend Favorite

Significance of Minimal Residual Disease in Lymphoid Malignancies

By  

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 111-119

Karger

Access to resources Recommend Favorite

Continuous Complete Hematological and Cytogenetic Remission with Molecular Minimal Residual Disease 9 Years after Discontinuation of Interferon-α in a Patient with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 109-112

Karger

Access to resources Recommend Favorite

Detection of Minimal Residual Disease in Acute Myelogenous Leukemia

By  

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 40-54

Karger

Access to resources Recommend Favorite

Doxorubicin variants for hematological malignancies

By Visani Giuseppe   Isidori Alessandro  

Nanomedicine, Vol. 6, Iss. 2, 2011-02 ,pp. : 303-306

Future Medicine

Access to resources Recommend Favorite